Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S -transferase genetic polymorphisms as predictive biomarkers of disease outcome-Reference-Cited by-同舟云学术

Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S -transferase genetic polymorphisms as predictive biomarkers of disease outcome

Published:2003-06-01 Issue:3 Volume:8 Page:156-161
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:
Short-container-title:International Journal of Clinical Oncology

Author:

Medeiros Rui,Pereira Deolinda,Afonso No�mia,Palmeira Carlos,Faleiro Cristina,Afonso-Lopes Carlos,Freitas-Silva Margarida,Vasconcelos Andr�,Costa Sandra,Os�rio Teresa,Lopes Carlos

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-003-0318-8.pdf

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models;International Journal of Clinical Oncology;2024-05-20

2. Practical biomarkers and robust multiplex models for the prediction of response to the promising first-line chemotherapy: A theranostic study in metastatic ovarian cancer patients with residual peritoneal tumors;2023-01-19

3. Practical biomarkers and robust multiplex models for the prediction of response to promising first-line chemotherapy: A theranostic study in metastatic ovarian cancer patients with residual peritoneal tumors;2023-01-12

4. The molecular and cellular basis of copper dysregulation and its relationship with human pathologies;The FASEB Journal;2021-08-14

5. Clinical significance and biological mechanisms of glutathione S-transferase mu gene family in colon adenocarcinoma;BMC Medical Genetics;2020-06-15